ImmixBio Announces Gabriel Morris as Chief Financial Officer and a Member of the Board of Directors

LOS ANGELES: LOS ANGELES, July 6, 2021 /PRNewswire/ -- Immix Biopharma, Inc. ("ImmixBio"), a biotechnology company pioneering Tissue-Specific Therapeutics (TSTx)™ for oncology and inflammation, today announced that Gabriel Morris has joined its leadership team as Chief Financial Officer and a member of the Board of Directors. Mr. Morris has been...

Click to view original post